UKRI’s Official Development Assistance (ODA) budget has been cut twice since 2021 — first when the UK reduced ODA from 0.7% to 0.5% of gross national income, then again from February 2025, when government set a further target of 0.3% of GNI by 2027. For grant holders, these UKRI funding cuts mean tighter ODA-eligible budgets, reprofiled projects and sharper competition for what remains of the international development research portfolio.
Official Development Assistance is UK government aid spending that, under the OECD Development Assistance Committee framework the UK follows, must primarily promote the economic development and welfare of countries on the OECD DAC list of ODA recipients. UKRI channels a portion of its research and innovation budget through ODA-eligible programmes such as the Global Challenges Research Fund (GCRF) and the International Science Partnerships Fund (ISPF), and this ODA-specific funding line has been reduced independently of — and more severely than — UKRI’s core domestic science budget.
- What are the UKRI ODA funding cuts?
- How did the 2021 ODA reduction affect grant holders?
- What do the 2025–2027 ODA reductions mean for UKRI grants?
- What should current and prospective ODA grant holders do now?
- Answer-first Q&A: UKRI ODA funding cuts
- Implications and what happens next
What Are the UKRI ODA Funding Cuts?
The UKRI ODA funding cuts refer to two distinct reductions to the ring-fenced aid spending that UKRI channels into development-focused research. The first came in February 2021, when the UK government cut total ODA spending from 0.7% to 0.5% of GNI, citing the fiscal impact of the Covid-19 pandemic. The second came in February 2025, when the government set a further reduction path to 0.3% of GNI by 2027, this time to fund an increase in defence spending.
These cuts sit apart from the wider 2026 restructuring of UKRI’s £8 billion domestic research and innovation budget — the grant pauses, “always open” transitions and STFC savings programme already covered in general UKRI funding-cuts reporting. ODA is a distinct, ring-fenced funding line governed by international aid rules, not by UKRI’s strategic prioritisation exercise, so it is cut and managed on a different timetable by a different part of government — the Treasury and the Foreign, Commonwealth & Development Office (FCDO) — than UKRI’s domestic “buckets.”
How Did the 2021 ODA Reduction Affect Grant Holders?
The 2021 cut hit UKRI’s ODA portfolio disproportionately hard. According to written evidence submitted to the House of Commons Science, Innovation and Technology Committee, UKRI received £422 million in ODA funding in 2020-21, a year-on-year reduction of roughly 70% — considerably steeper than the roughly 50% cut (from £1.4 billion to £706 million) applied to the then Department for Business, Energy and Industrial Strategy’s ODA budget over the same period.
UKRI responded by offering grant holders on GCRF and Newton Fund awards a limited set of options:
- Termination of the award where the project could not be meaningfully continued at a reduced scale.
- Reprofiling, adjusting project scope, partners or timelines to fit a smaller budget.
- A case for exceptional funding, submitted where neither termination nor reprofiling was workable.
UKRI also lifted virement restrictions across GCRF and Newton Fund grants, giving award holders flexibility to move funds between budget lines to protect priority activities. Grant holder surveys at the time found that most UK-based and in-country respondents expected the cuts to harm the communities the research was meant to benefit, and sector bodies including the Development Studies Association called for international partners to receive the same contractual protection as UK-based researchers.
What Do the 2025–2027 ODA Reductions Mean for UKRI Grants?
The 2025 announcement is a second, separate contraction. The government’s decision to reduce total UK ODA spending to 0.3% of GNI by 2027 was made to help fund a rise in defence spending, and it lands on top of a portfolio that had never fully recovered from the 2021 cut. UKRI published its own ODA review on 14 May 2025, examining options to mitigate the impact of the reduced allocation on its remaining GCRF and Newton Fund commitments.
Reporting on the FCDO’s published ODA allocations for 2026/27 to 2028/29 indicates that bilateral aid — the category most research partnerships fall under — is being cut more heavily than multilateral aid, with Africa and the Middle East and North Africa region facing the largest reductions, and humanitarian aid, global health and education programmes among the hardest-hit sectors. Because UKRI’s development-research spending sits within the wider bilateral ODA envelope, these sector and regional priorities directly shape which UKRI-funded partnerships are likely to be protected or reduced.
| Milestone | UK ODA target | Effect on UKRI’s ODA-eligible research |
|---|---|---|
| Pre-2021 baseline | 0.7% of GNI | GCRF and Newton Fund at planned commitment levels |
| February 2021 | 0.5% of GNI | UKRI’s ODA budget fell roughly 70% year-on-year; termination, reprofiling and exceptional-funding options offered |
| 14 May 2025 | 0.5% of GNI (interim) | UKRI ODA review published to plan for further reductions |
| By 2027 | 0.3% of GNI (target) | Bilateral ODA facing the steepest cuts; sharper competition for renewal and new ODA-eligible awards |
What Should Current and Prospective ODA Grant Holders Do Now?
Grant holders with live or planned UKRI ODA awards should treat the funding line as structurally constrained through at least 2027, not as a temporary pause. Practical steps include:
- Confirm commitment status directly with your UKRI council rather than assuming an existing award is automatically protected — legal commitments for prior awards are generally honoured, but renewal and extension decisions are being made against a shrinking envelope.
- Build reprofiling flexibility into proposals, mirroring the virement and scope-adjustment approach UKRI used during the 2021 cuts, so a project can absorb a mid-award budget reduction without collapsing.
- Prioritise equitable partner treatment, applying a “do no harm” approach that protects in-country and Global South partners’ contracts and payments on the same terms as UK-based staff.
- Diversify beyond a single ODA-eligible instrument, exploring co-funding through Horizon Europe association, the International Science Partnerships Fund, or bilateral country-level schemes where GCRF or Newton Fund successors have narrowed.
- Track FCDO sector and regional priorities, since bilateral ODA cuts are not applied evenly — health, education and humanitarian-linked research in Africa and the MENA region face the steepest reductions.
Answer-First Q&A: UKRI ODA Funding Cuts
Is UKRI ODA funding being cut again?
Yes. UKRI’s Official Development Assistance funding remains under sustained pressure following the UK government’s February 2025 decision to reduce total ODA spending to 0.3% of gross national income by 2027. UKRI published an ODA review in May 2025 to plan how this affects its Global Challenges Research Fund and Newton Fund portfolios.
What is ODA funding at UKRI?
Official Development Assistance is UK government aid spending that must promote the economic development and welfare of low- and middle-income countries. UKRI channels ODA through programmes including the Global Challenges Research Fund and the International Science Partnerships Fund, subject to strict eligibility rules and Researchfish outcome reporting.
Will UKRI honour existing ODA grant commitments?
UKRI has generally protected legal commitments for already-awarded projects, but new and renewal ODA awards face tighter competition as the overall envelope shrinks. Grant holders should confirm commitment status directly with their UKRI council rather than assume automatic continuity through to project completion.
How is ODA funding different from UKRI’s core science budget?
ODA funding is ring-fenced aid spending tied to development outcomes in eligible countries, separate from UKRI’s domestic research and innovation budget, which is rising toward almost £10 billion annually by 2030. Cuts to the aid budget do not automatically reduce curiosity-driven domestic grants, but they do shrink international development-focused funding specifically.
Implications and What Happens Next
For institutions, the practical implication is that ODA-eligible research administration now needs its own risk register, separate from general UKRI grant-pipeline planning. Research offices should flag ODA-funded projects for early review, model reprofiling scenarios before a reduction is announced rather than after, and ensure partnership agreements with Global South institutions include contingency clauses for budget reductions.
Sector bodies continue to advocate for a return to the 0.7% ODA commitment, but the government’s 2025 decision was framed as a multi-year fiscal choice tied to defence spending, not a temporary measure. Grant holders and research administrators managing UKRI ODA awards should plan on a constrained funding line running through the current spending review period to 2027, with FCDO bilateral sector and regional priorities — not UKRI’s domestic strategic “buckets” — determining which development-research partnerships come under the most pressure next.
